StockData
Citius Oncology, Inc. logo

Citius Oncology, Inc. (CTOR) stock

CTORNasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 2/30
$0.56+0.01 (+1.79%)

Close on Nov 18, 2026Market cap $51.83MP/E –Yield –

Citius Oncology shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Citius Oncology's shares outstanding was 108M at Jun 30, 2026. For fiscal 2025 it was 73M, up 281.0% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Sep 30, 202573M+281.0%
FY2022Dec 31, 202219M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q3 FY2026CQ2 2026Jun 30, 2026108M+50.8%
Q2 FY2026CQ1 2026Mar 31, 2026100M+39.8%
Q1 FY2026CQ4 2025Dec 31, 202587M+22.2%
Q4 FY2025CQ3 2025Sep 30, 202578M+531.0%
Q3 FY2025CQ2 2025Jun 30, 202572M+232.8%
Q2 FY2025CQ1 2025Mar 31, 202572M+232.8%
Q1 FY2025CQ4 2024Dec 31, 202472M+189.4%
Q4 FY2022CQ4 2022Dec 31, 202212M-42.2%
Q3 FY2022CQ3 2022Sep 30, 202222M–
Q2 FY2022CQ2 2022Jun 30, 202222M–
Q1 FY2022CQ1 2022Mar 31, 202225M–
Q3 FY2021CQ3 2021Sep 30, 202122M–

More Citius Oncology figures

See a number that looks wrong?